Disclosures: Dr. Beidas has disclosed that she is a consultant for Merck & Co., Inc. Schnoll has disclosed that he receives grant/research support from Pfizer, and is a consultant for Pfizer, GlaxoSmithKline, and Curaleaf. The remaining authors have no conflicts to disclose.
Funding: This project was supported by a grant from the NCI (P30 CA016520-41S4) and from the National Institute on Drug Abuse (K24 DA045244). Dr. Jenssen is supported, in part, by the NCI (K08CA226390).
Disclaimer: The views expressed here are those of the authors only and do not represent any official position of the NCI or NIH.